Evidence map›Paper›PMID 34826235›Full record

ArticleScience advances2021

Low-flow intussusception and metastable VEGFR2 signaling launch angiogenesis in ischemic muscle.

John-Michael Arpino, Hao Yin, Emma K Prescott, Sabrina C R Staples, Zengxuan Nong, Fuyan Li, Jacqueline Chevalier, Brittany Balint, Caroline O'Neil, Rokhsana Mortuza and 9 more

Abstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Intussusceptive angiogenesis-on-a-chip: Evidence for transluminal vascular bridging by endothelial delamination.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

John-Michael ArpinoRobarts Research Institute, Western University, London, Canada.ORCID 0000-0001-5361-0097
Hao YinRobarts Research Institute, Western University, London, Canada.ORCID 0000-0002-0018-3228
Emma K PrescottRobarts Research Institute, Western University, London, Canada.ORCID 0000-0003-0588-5621
Sabrina C R StaplesRobarts Research Institute, Western University, London, Canada.ORCID 0000-0002-4000-4693
Zengxuan NongRobarts Research Institute, Western University, London, Canada.
Fuyan LiRobarts Research Institute, Western University, London, Canada.
Jacqueline ChevalierRobarts Research Institute, Western University, London, Canada.ORCID 0000-0002-7278-5463
Brittany BalintRobarts Research Institute, Western University, London, Canada.ORCID 0000-0002-7520-9509
Caroline O'NeilRobarts Research Institute, Western University, London, Canada.
Rokhsana MortuzaRobarts Research Institute, Western University, London, Canada.
Stephanie MilkovichRobarts Research Institute, Western University, London, Canada.
Jason J LeeRobarts Research Institute, Western University, London, Canada.ORCID 0000-0002-3865-2675
Daniel LorussoRobarts Research Institute, Western University, London, Canada.ORCID 0000-0001-9263-0912
Martin SandigDepartment of Anatomy and Cell Biology, Western University, London, Canada.ORCID 0000-0003-0890-3645
Douglas W HamiltonDepartment of Anatomy and Cell Biology, Western University, London, Canada.
David W HoldsworthRobarts Research Institute, Western University, London, Canada.ORCID 0000-0002-0603-5322
Tamie L PoeppingDepartment of Physics and Astronomy, Western University, London, Canada.ORCID 0000-0002-4953-5204
Christopher G EllisRobarts Research Institute, Western University, London, Canada.ORCID 0000-0002-7760-1846
J Geoffrey PickeringRobarts Research Institute, Western University, London, Canada.ORCID 0000-0001-6474-3274

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Efforts to promote sprouting angiogenesis in skeletal muscles of individuals with peripheral artery disease have not been clinically successful. We discovered that, contrary to the prevailing view, angiogenesis following ischemic muscle injury in mice was not driven by endothelial sprouting. Instead, real-time imaging revealed the emergence of wide-caliber, primordial conduits with ultralow flow that rapidly transformed into a hierarchical neocirculation by transluminal bridging and intussusception. This process was accelerated by inhibiting vascular endothelial growth factor receptor-2 (VEGFR2). We probed this response by developing the first live-cell model of transluminal endothelial bridging using microfluidics. Endothelial cells subjected to ultralow shear stress could reposition inside the flowing lumen as pillars. Moreover, the low-flow lumen proved to be a privileged location for endothelial cells with reduced VEGFR2 signaling capacity, as VEGFR2 mechanosignals were boosted. These findings redefine regenerative angiogenesis in muscle as an intussusceptive process and uncover a basis for its launch.

Identifiers

PMID34826235
PMCPMC8626079

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.